Efficacy Study of Triamcinolone and Bevacizumab Intravitreal for Treatment of Diabetic Macular Edema

NCT00737971 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

142

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

DRUG: Bevacizumab intravitreal
DRUG: Triamcinolone
DRUG: Triamcinolone + Bevacizumab

Sponsor

Rubens Belfort Jr.